Načítá se...
Pre-Clinical Evaluation of a Themosensitive Gel Containing Epothilone B and mTOR/Hsp90 Targeted Agents in an Ovarian Tumor Model
Despite clinical remission of epithelial ovarian cancer (EOC) after surgical resection and first-line chemotherapy, about 60% of patients will re-develop peritoneal metastasis and about 50% will relapse with chemoresistant disease. Clinical studies suggest that intra-peritoneal (i.p.) chemotherapy e...
Uloženo v:
| Vydáno v: | J Control Release |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722673/ https://ncbi.nlm.nih.gov/pubmed/29056443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2017.10.022 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|